The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
AIMS: Previous studies on biventricular (BIV) pacing and cardiac resynchronization therapy-defibrillator (CRT-D) efficacy have used arbitrarily chosen BIV pacing percentages, and no study has employed implantable cardioverter defibrillator (ICD) patients as a control group. METHODS AND RESULTS: Using Kaplan-Meier plots, we estimated the threshold of BIV pacing percentage needed for CRT-D to be superior to ICD on the end-point of heart failure (HF) or death in 1219 left bundle branch block (LBBB) patients in the MADIT-CRT trial. Patients were censored at the time of crossover. In multivariable Cox analyses, no difference was seen in the risk of HF/death between ICD and CRT-D patients with BIV pacing ≤90% [HR = 0.78 (0.47-1.30), P = 0.344], and with increasing BIV pacing the risk of HF/death was decreased [CRT-D BIV 91-96% vs. ICD: HR = 0.63 (0.42-0.94), P = 0.024 and CRT-D BIV ≥97% vs. ICD: HR = 0.32 (0.23-0.44), P < 0.001]. The risk of death alone was reduced by 52% in CRT-D patients with BIV ≥97% (HR = 0.48, P < 0.016), when compared with ICD patients. Within the CRT-D group, for every 1 percentage point increase in BIV pacing, the risk of HF/death and death alone significantly decreased by 6 and 10%, respectively. Increasing BIV pacing percentage was associated with significant reductions in left ventricular volume. CONCLUSION: In patients with LBBB, who were in sinus rhythm at enrolment, BIV pacing exceeding 90% was associated with a benefit of CRT-D in HF/death when compared with ICD patients. Furthermore, BIV pacing ≥97% was associated with an even further reduction in HF/death, a significant 52% reduction in death alone, and increased reverse remodelling. Clinical trials.gov identifier: NCT00180271.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was also administered in LDL receptor-null mice and liver apo C-III levels were also reduced [114, 115].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [115]
In the citing paper
“Neointimal formation and macrophage infiltration were also attenuated, suggesting that pemafibrate reduced CD64-positive cells in monocytes, inhibited M1 polarization in IFNγ-stimulated macrophages, and increased the expression of NcoR1/2, co-repressor of proinflammatory cytokines.”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [115]
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Self-citationThe Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,276
Self-citationBristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Higgins, S. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906431 · Cited by 3,157 · cited 2×
“As previously described, the primary end-point of the MADIT-CRT study was a combined endpoint of hospitalization for HF events or death.(1) Accordingly, the end-point of HF/death was used to determine the BIV pacing efficacy threshold of CRT-D.”
BackgroundMethodSelf-citationCardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
Tang, A. S. L., Wells, G. A., Talajic, M., Arnold, M. O., Sheldon, R., Connolly, S., Hohnloser, S. H., Nichol, G., Birnie, D. H., Sapp, J. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1009540 · Cited by 1,859 · cited 1×
“These factors are consistent with factors other studies have found to be associated with a better CRT-D outcome.(4,16,17) The fact that low ectopy burden and no prior ventricular tachyarrhythmias were both highly associated with increased probability of achieving high BIV pacing percentage is consistent with the notio…”
ResultZareba, W., Klein, H., Cygankiewicz, I., Hall, W. J., McNitt, S., Brown, M., Cannom, D., Daubert, J. P., Eldar, M., Gold, M. R., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.960898 · Cited by 839
Self-citationGasparini, M., Auricchio, A., Regoli, F., Fantoni, C., Kawabata, M., Galimberti, P., Pini, D., Ceriotti, C., Gronda, E., Klersy, C., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.056 · Cited by 381
Hayes, D. L., Boehmer, J. P., Day, J. D., Gilliam, F. R., Heidenreich, P. A., Seth, M., Jones, P. W., & Saxon, L. A. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.04.015 · Cited by 346
Sipahi, I. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.247 · Cited by 295
Koplan, B. A., Kaplan, A. J., Weiner, S., Jones, P. W., Seth, M., & Christman, S. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.043 · Cited by 276
Cited by
Wilkoff, B. L., Fauchier, L., Stiles, M. K., Morillo, C. A., Al-Khatib, S. M., Almendral, J., Aguinaga, L., Berger, R. D., Cuesta, A., Daubert, J. P., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.11.018 · Cited by 301
Self-citationWilkoff, B. L., Fauchier, L., Stiles, M. K., Morillo, C. A., Al-Khatib, S. M., Almendral, J., Aguinaga, L., Berger, R. D., Cuesta, A., Daubert, J. P., et al. (2016) · Europace · doi:10.1093/europace/euv411 · Cited by 243
Self-citationYamashita, S., Masuda, D., & Matsuzawa, Y. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-0823-5 · Cited by 191
Wilkoff, B. L., Fauchier, L., Stiles, M. K., Morillo, C. A., Al‐Khatib, S. M., Almendral, J., Aguinaga, L., Berger, R. D., Cuesta, A., Daubert, J. P., et al. (2016) · Journal of Arrhythmia · doi:10.1016/j.joa.2015.12.001 · Cited by 50
Self-citationLeclercq, C., Burri, H., Delnoy, P. P. H. M., Rinaldi, C. A., Sperzel, J., Calò, L., de la Concha, J. F., Fusco, A. M., Al-Samadi, F., Lee, K., et al. (2023) · EP Europace · doi:10.1093/europace/euad294 · Cited by 48
Metadata
- Authors
- Ruwald, A.-C., Kutyifa, V., Ruwald, M. H., Solomon, S., Daubert, J. P., Jons, C., Brenyo, A., McNitt, S., Do, D., Tanabe, K., Al-Ahmad, A., Wang, P., Moss, A. J., & Zareba, W.
- Affiliations
- Gentofte Hospital (DK)
- University of Rochester Medicine (US)
- Brigham and Women's Hospital (US)
- Duke Medical Center (US)
- Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
- Prisma Health (US)
- Stanford Medicine (US)
- Division of Cardiovascular Medicine, Stanford University, Stanford, CA, USA
- Heart Research Follow-up Program, University of Rochester Medical Center, 265 Crittenden Blvd. CU 420653, Rochester, NY 14642, USA
- Corresponding author
- Ruwald, Anne-Christine
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-08-11
- Volume
- 36
- Issue
- 7
- Pages
- 440-448
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2095788644
- Cited by
- 74
- References
- 20
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 10 · 2022: 3 · 2021: 7 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 11 · 2016: 10 · 2015: 9 · 2014: 2
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Rochester
- Boston Scientific Corporation
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- cardiac resynchronization therapy, CRT-D, implantable cardioverter-defibrillator, left bundle branch block, heart failure, mortality, reverse remodeling, left ventricular volume
- MeSH terms
- Aged, Bundle-Branch Block, Female, Heart Failure, Humans, Male, Middle Aged, Treatment Outcome, Defibrillators, Implantable, Ventricular Remodeling, Kaplan-Meier Estimate, Cardiac Resynchronization Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. https://app.cochat.ai/papers/10.1093/eurheartj/ehu294
- The paper
- Ruwald, A.-C., Kutyifa, V., Ruwald, M. H., Solomon, S., Daubert, J. P., Jons, C., Brenyo, A., McNitt, S., Do, D., Tanabe, K., Al-Ahmad, A., Wang, P., Moss, A. J., & Zareba, W. (2015). The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. European Heart Journal. https://doi.org/10.1093/eurheartj/ehu294
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.